Karen A. Dawes, Director at REPLIGEN CORP (RGEN), sold 570 shares at $176.85 ($101K) on 2021-05-11, disclosed to the SEC on 2021-05-13.
Seasonal sale ($101k) by Director — this insider has traded RGEN in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $176.85 | 285 | $50K | 50.0% |
| 2 | $176.85 | 285 | $50K | 50.0% |
| Total | $176.85 avg | 570 | $101K | 100% |
| Filing → |
| RGEN | SELL | 2023-08-30 | $146K | — | Filing → |
| RGEN | SELL | 2022-09-09 | $352K | — | Filing → |
| RGEN | SELL | 2022-05-26 | $4.4M | — | Filing → |